Showing results (71-80 of 122) with videos related to
Sort By:
Pageof 13
Cell Host & Microbe|December 4, 2014
Macrophage infection via selective capture of HIV-1-infected CD4+ T cellsAmy E Baxter, Rebecca A Russell, Christopher J A Duncan, et al.Plos One|June 16, 2012
Comparison of clinical and parasitological data from controlled human malaria infection trialsMeta Roestenberg, Geraldine A O'Hara, Christopher J A Duncan, et al.Journal of Cachexia, Sarcopenia and Muscle|March 8, 2022
Clinical frailty, and not features of acute infection, is associated with late mortality in COVID-19: a retrospective cohort studyNikolaos I Vlachogiannis, Kenneth F Baker, Georgios Georgiopoulos, et al.Clinical and Translational Science|August 14, 2012
Incidental diagnosis in healthy clinical trial subjectsChristopher J A Duncan, Rosalind Rowland, Patrick J Lillie, et al.Frontiers in Immunology|September 26, 2022
mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individualsStephanie Longet, Alexander Hargreaves, Saoirse Healy, et al.Immunology|December 6, 2013
Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infectionSean C Elias, Prateek Choudhary, Simone C de Cassan, et al.Epidemiology and Infection|August 29, 2020
COVID-19: public health management of the first two confirmed cases identified in the UKB Holden, A Quinney, S Padfield, et al.Journal of Virology|July 12, 2013
Immune focusing and enhanced neutralization induced by HIV-1 gp140 chemical cross-linkingT Schiffner, L Kong, C J A Duncan, et al.Ebiomedicine|December 24, 2023
Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19Luke Milross, Bethany Hunter, David McDonald, et al.Nature Communications|July 3, 2025
Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trialChong Ma, Jiejun Du, Lan Lan, et al.Pageof 13